2016 ICPE Presentation: Assessment of the US Food and Drug Administration’s Sentinel Analysis Tools: Angiotensin-Converting Enzyme Inhibitors and Angioedema

Project Title 2016 ICPE Presentation: Assessment of the US Food and Drug Administration’s Sentinel Analysis Tools: Angiotensin-Converting Enzyme Inhibitors and Angioedema
Date
Thursday, August 25, 2016
Location
Medical Product
angiotensin-converting enzyme (ACE) inhibitor
Health Outcome
angioedema
Host
Authors

Joshua Gagne

Related Assessments